Cardiovascular Risk Factors in Type 2 Diabetes Management
Summary
Type 2 diabetes is characterised by chronic hyperglycaemia and associated metabolic disturbances that substantially increase the risk of cardiovascular disease. Key modifiable risk factors include poor glycaemic control, hypertension, dyslipidaemia, central adiposity and systemic inflammation. Effective management demands a multifactorial approach: optimising blood‐glucose levels, intensive blood‐pressure reduction and lipid‐lowering therapy, combined with dietary modification, weight management and regular physical activity. Recent advances have highlighted the cardioprotective effects of newer antihyperglycaemic agents—specifically SGLT2 inhibitors and GLP-1 receptor agonists—that reduce heart failure, atherothrombotic events and renal dysfunction beyond their glucose‐lowering properties. Personalised risk stratification, early intervention and coordinated care pathways are essential to translate these findings into global reductions in cardiovascular morbidity and mortality among people with type 2 diabetes.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Cardiovascular Risk Factors in Type 2 Diabetes Management publication trend
The graph below shows the total number of articles in cardiovascular risk factors in type 2 diabetes management across all publications each year (not limited to Nature Index journals).
Technical terms
Glycosylated haemoglobin (HbA1c): A biomarker reflecting average blood-glucose levels over the preceding two to three months, used to monitor long-term glycaemic control.
Fasting plasma glucose (FPG): The concentration of glucose in the blood after an overnight fast, an indicator of baseline glycaemic status.
Dyslipidaemia: An abnormal lipid profile characterised by elevated total cholesterol, low-density lipoprotein or triglycerides, and/or reduced high-density lipoprotein, contributing to atherogenesis.
Macrovascular complications: Cardiovascular disorders arising from large-vessel damage in diabetes, including coronary artery disease, cerebrovascular disease and peripheral arterial disease.
SGLT2 inhibitors: A class of antihyperglycaemic drugs that reduce renal glucose reabsorption, providing glycaemic control and cardiovascular protection.
GLP-1 receptor agonists: Agents that mimic incretin hormones to enhance insulin secretion, slow gastric emptying and confer cardiovascular benefits.
References
- Glycosylated Hemoglobin in Relationship to Cardiovascular Outcomes and Death in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLOS ONE (2012).
- Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study. BMC Cardiovascular Disorders (2018).
- Association of longitudinal trajectories of fasting plasma glucose with all-cause and cardiovascular mortality among a Chinese older population: a retrospective cohort study. BMC Public Health (2024).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.